AQP4抗体、MOG抗体或双阴性视神经脊髓炎谱系疾病患者的妊娠结局
这项回顾性多中心国际研究分析了89次妊娠(46次AQP4抗体阳性、30次MOG抗体阳性、13次双阴性)在58例NMOSD患者中的情况。研究发现妊娠期年化复发率(ARR)在各血清状态组均低于孕前,但AQP4抗体阳性患者产后ARR高于孕前(p<0.01);妊娠前或妊娠期使用免疫抑制治疗(IST)者妊娠期及产后12个月复发更少(26% vs 53%,p=0.04)。
要点
- AQP4抗体阳性患者产后首个三月期ARR较孕前反弹升高,需加强产后监测。
- 妊娠前或妊娠期使用IST可降低妊娠期及产后12个月复发风险(26% vs 53%)。
- 流产发生率11%,主要见于AQP4抗体阳性且有流产史者;子痫前期2例均为AQP4抗体阳性。
核心结论
- 产后首个三月期ARR反弹高于孕前仅见于AQP4抗体阳性患者。
- 妊娠前或妊娠期使用IST可降低这些患者的复发风险。
研究设计与样本
- 回顾性多中心国际研究,纳入58例NMOSD患者的89次妊娠(46次AQP4-Ab、30次MOG-Ab、13次双阴性)。
- 计算孕前12个月、妊娠各三月期及产后的平均年化复发率(ARR),并记录流产、子痫前期等事件。
主要发现
- 与孕前相比,各血清状态组妊娠期ARR均较低。
- AQP4-Ab阳性患者产后ARR高于孕前(p<0.01)。
- 流产10次(11%),主要见于AQP4-Ab阳性(伴或不伴IST)且有流产史者。
- 子痫前期2例(2%),均为AQP4-Ab阳性。
关键数值与推荐
- AQP4-Ab阳性患者产后ARR高于孕前,p<0.01。
- IST组妊娠期及产后12个月复发率26%,未治疗组53%,p=0.04。
- 流产发生率11%(10次妊娠),子痫前期发生率2%(2例)。
临床怎么用
- 对AQP4-Ab阳性NMOSD患者应重点监测产后复发,尤其产后早期。
- 计划妊娠或妊娠期可考虑维持IST以降低妊娠期及产后复发风险。
- 对有流产史的AQP4-Ab阳性患者应加强妊娠管理。
局限性
- 回顾性研究设计,可能存在信息偏倚。
- 样本量较小(89次妊娠),双阴性组仅13次妊娠。
- IST定义限于妊娠前3个月内或妊娠期使用,未进一步分层分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the effects of pregnancy on neuromyelitis optica spectrum disorder (NMOSD) according to patients' serostatus and immunosuppressive therapy (IST). METHODS: We performed a retrospective multicenter international study on patients with NMOSD. Patients were tested for aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). Informative pregnancies were reported when NMOSD onset occurred before or during pregnancy or up to 12 months postpartum. The mean annualized relapse rate (ARR) was calculated for the 12 months before conception, for each trimester of pregnancy, and postpartum. Events such as miscarriage, abortion, and preeclampsia were reported. IST was considered if taken in the 3 months before or during pregnancy. RESULTS: We included 89 pregnancies (46 with AQP4-Ab, 30 with MOG-Ab, and 13 without either Ab) in 58 patients with NMOSD. Compared to the prepregnancy period, the ARR was lower during pregnancy in each serostatus group and higher during the postpartum period in patients with AQP4-Ab (p < 0.01). Forty-eight percent (n = 31) of pregnancies occurred during IST and these patients presented fewer relapses during pregnancy and the 12 months postpartum than untreated patients (26% vs 53%, p = 0.04). Miscarriages occurred in 10 (11%) pregnancies, and were mainly in patients with AQP4-Ab (with or without IST) and a previous history of miscarriage. Preeclampsia was reported in 2 (2%) patients who were AQP4-Ab-positive. CONCLUSION: We found a rebound in the ARR during the first postpartum trimester that was higher than the prepregnancy period only in AQP4-Ab-positive patients. Taking IST just before or during pregnancy reduces the risk of relapses in these conditions.
引用
- Collongues N, Alves Do Rego C, Bourre B, et al. Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder. Neurology. 2021. PMID: 33627499. doi:10.1212/WNL.0000000000011744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。